Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.
Lombe KasondeDavid TordrupAliya NaheedWu ZengShyfuddin AhmedZaheer Ud-Din BabaarPublished in: BMC health services research (2019)
Availability and affordability of NCD medicines are key concerns where the burden of NCD is rising. These findings show improvement from earlier studies, but room for further advances in availability and affordability of NCD medicines in Bangladesh. A small number of medicines are consistently expensive across sectors in Bangladesh, suggesting the need for strategies to address prices for certain medicines.